News — MitoChem Therapeutics, Inc.

News

MitoChem Therapeutics Receives $900,000 Foundation Fighting Blindness Award to Study Target and Mechanism of Action in Retinal Degeneration Diseases

September 21, 2023

SC Launch Inc. Announces Investment in MitoChem Therapeutics

September 06, 2022

Ichor Life Sciences Invests $1.5 Million in MitoChem Therapeutics For Ocular Aging Disease Research

August 15, 2022

Press Release: MitoChem Therapeutics to Present at Mitochondria-Targeted Drug Development Summit

February 23, 2022

Press Release: MitoChem Therapeutics Granted FDA Orphan Drug Designation for Treatment of Retinitis Pigmentosa